A Study to Test Long-term Treatment With Spesolimab in Patients With Fistulising Crohn's Disease Who Took Part in Previous Trials
Clinical trial NCT04362254 · TERMINATED
Trial details
- NCT number
- NCT04362254
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-15
- Primary completion
- 2022-05-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.